The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
Related posts
-
Gas N Wash plan clears Wheeling village board
Wheeling trustees on Monday approved the final plans for a Gas N Wash station on the... -
CTA shrugging off pandemic service lows; how about Metra and Pace?
The CTA is touting its comeback from COVID-19. How do Metra and Pace stack up? -
Bids due Friday for construction on Barrington Route 14 underpass
Bids are due Friday for construction of the long-awaited Route 14 underpass at the Canadian National...